Research Paper Volume 16, Issue 1 pp 285—298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Figure 9. Violin plot of MAGE-A11 expression and sensitivity to immunotherapy. (A) Anti-PD1 immunotherapy. (B) Anti-CTLA4 immunotherapy. (C) Anti-PD1 and CTLA4 immunotherapy. (D) Non-immunotherapy.